Thomas Flaten
Stock Analyst at Lake Street
(2.84)
# 1,566
Out of 5,173 analysts
37
Total ratings
33.33%
Success rate
2.94%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVAX Evaxion | Maintains: Buy | $11 → $9 | $3.88 | +131.96% | 4 | Mar 9, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $8 → $12 | $4.03 | +197.77% | 1 | Feb 17, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $25.75 | +101.94% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $22.00 | +127.27% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.95 | +205.08% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.19 | +182.13% | 1 | Nov 13, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $34.00 | +105.88% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $6.90 | +88.41% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $2.30 | +247.83% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.29 | +92.04% | 2 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.65 | +201.89% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $14.69 | +172.29% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.93 | +103.56% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $7.61 | +18.27% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $14.00 | +221.43% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.05 | +171.60% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $19.17 | +30.41% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.59 | +245,969.72% | 2 | Nov 17, 2022 |
Evaxion
Mar 9, 2026
Maintains: Buy
Price Target: $11 → $9
Current: $3.88
Upside: +131.96%
Insight Molecular Diagnostics
Feb 17, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $4.03
Upside: +197.77%
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $25.75
Upside: +101.94%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $22.00
Upside: +127.27%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.95
Upside: +205.08%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.19
Upside: +182.13%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $34.00
Upside: +105.88%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $6.90
Upside: +88.41%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $2.30
Upside: +247.83%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.29
Upside: +92.04%
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.65
Upside: +201.89%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $14.69
Upside: +172.29%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.93
Upside: +103.56%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $7.61
Upside: +18.27%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $14.00
Upside: +221.43%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.05
Upside: +171.60%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $19.17
Upside: +30.41%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.59
Upside: +245,969.72%